Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Genmab
Genmab
Incyte Corporation
Acerta Pharma BV
Hoffmann-La Roche
Ohio State University Comprehensive Cancer Center
Regeneron Pharmaceuticals
Mayo Clinic
University of Wisconsin, Madison
Barbara Ann Karmanos Cancer Institute
University of Rochester
University of Chicago
Memorial Sloan Kettering Cancer Center
Genmab